Acumen Pharmaceuticals, Inc

Call
Website
1210 Washington St # 1220
West Newton, MA 02465
+1 (617) 344-4190
https://acumenpharm.com

Acumen Pharmaceuticals, Inc., based in West Newton, MA, is dedicated to developing targeted treatments for Alzheimer's disease, aiming to enhance patients' quality of life by helping them hold onto their moments and create new ones. The company is driven by an experienced team focused on advancing therapies that address the toxic amyloid beta oligomers, which are key contributors to neurodegeneration associated with Alzheimer's.

Among its leading candidates is abirnetug (ACU193), a monoclonal antibody designed to selectively target these harmful soluble aggregates, potentially offering disease-modifying benefits and improved safety for early Alzheimer's patients. Acumen's commitment to innovative research seeks to drive the field forward and achieve better outcomes for those affected by this challenging condition.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Alkermes PLC
Services, nec, nec, Real estate managers, Vitamin, nutrient, and hematinic preparations for human use

Alkermes PLC

Alkermes is a worldwide pharmaceutical company that develops controlled, sustained-release injectable drugs using with its trademark ProLease and Medisorb technologies. Located in Massachusetts, the company also develops inhaled formulations from its proprietary pulmonary technology. Alkermes has partnered with Johnson & Johnson to develop Riserpdal Consta, an antipsychotic drug used in the treatment of schizophrenia. Risperdal Consta is approved for sale in more than 50 countries that include the United States, United Kingdom and Germany. In addition to a host of partnered products, the ocmpany is also active in the development of several promising proprietary products, such as Vivitrex, a long-acting injectable form of naltrexone for alcohol dependence. Alkermes is headquartered in Cambridge, Mass.
Services, nec, nec, Vitamin, nutrient, and hematinic preparations for human use, Surgical instruments and apparatus

X-COR Therapeutics

X-COR Therapeutics is a Baltimore-based medical device company dedicated to creating the first commercially available extracorporeal CO2 removal device that utilizes ultra-low-blood flow technology. Their innovative solution aims to treat patients experiencing hypercarbic respiratory failure, offering a more accessible, affordable, and effective alternative to existing therapies. Founded by a team of experienced professionals with expertise in pulmonary medicine, engineering, and business development, X-COR's patent-pending system allows for the safe removal of excess CO2 from patients' blood using a hybrid approach. This technology enables broader adoption across healthcare settings, empowering more clinicians to provide critical care to individuals suffering from respiratory conditions. Generated from the website
Eating places, Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
United States›Massachusetts›West Newton›Acumen Pharmaceuticals, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.